hero section gradient
16 handpicked stocks

Race to Four Trillion

Invest in the companies building the foundation of the AI revolution. These carefully selected stocks represent crucial suppliers and enablers benefiting from Nvidia and Microsoft's historic race to $4 trillion valuations and their unprecedented spending on AI infrastructure.

Author avatar

Han Tan | Market Analyst

Published on June 30

Your Basket's Financial Footprint

Summary and key takeaways for the 'Race to Four Trillion' basket based on provided market capitalisation breakdown.

Key Takeaways for Investors:
  • Large-cap dominance generally implies more stability, lower volatility and closer tracking of broad market moves.
  • Treat as a core holding for diversified portfolios rather than a speculative, high-risk growth play.
  • Expect steady, long-term appreciation rather than explosive short-term gains; outcomes are not guaranteed.
Total Market Cap
  • TSM: $1.23T

  • ASML: $400.56B

  • SMCI: $32.58B

  • Other

About This Group of Stocks

1

Our Expert Thinking

As Nvidia and Microsoft compete for $4T valuations, they're pouring billions into AI infrastructure. This massive spending creates a ripple effect, benefiting the entire supply chain of companies that provide the essential hardware, software, and facilities needed to build the AI economy.

2

What You Need to Know

This collection focuses on companies across the entire AI technology value chain – from chip manufacturing and design to data centers and power management. These stocks offer exposure to the durable growth cycle created by the unprecedented capital investment in artificial intelligence infrastructure.

3

Why These Stocks

These companies were selected because they provide critical components and services that the AI giants can't build without. From advanced semiconductors and high-bandwidth memory to specialized cooling systems and networking equipment, each plays an essential role in the expanding AI ecosystem.

Why You'll Want to Watch These Stocks

💰

The $1 Trillion Spending Wave

Microsoft, Nvidia, and other tech giants are pouring unprecedented billions into AI infrastructure. These suppliers are the direct beneficiaries of this massive capital allocation, creating a durable growth cycle.

🔍

Beyond the Obvious AI Names

While everyone focuses on Nvidia and Microsoft, these essential suppliers often fly under the radar despite their critical role in the AI ecosystem. These companies represent the "picks and shovels" of the AI gold rush.

🌐

The Entire Tech Value Chain

This collection spans the full technology value chain - from advanced chip manufacturing and design software to data centers and the power infrastructure required to run them. It's a comprehensive way to invest in all aspects of the AI buildout.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Tech Stocks (AI Valuation Reset) Present Potential Entry

Tech Stocks (AI Valuation Reset) Present Potential Entry

Recent market turmoil, driven by concerns over AI stock valuations, has led to a significant drop in global markets. This correction creates a potential opportunity to invest in fundamentally sound technology companies at more attractive prices.

Walmart Succession Plan Explained | Market Effects

Walmart Succession Plan Explained | Market Effects

Walmart announced a CEO transition, with veteran John Furner taking the helm, which could create opportunities for competitors. This leadership change at a retail giant may cause short-term uncertainty, potentially benefiting other major players in the retail space.

Biotech Buyout Candidates (Post-Merck Acquisition)

Biotech Buyout Candidates (Post-Merck Acquisition)

Merck's $9.2 billion acquisition of Cidara Therapeutics for its antiviral drug pipeline signals a broader industry trend. This creates an investment opportunity in other biotech companies with promising late-stage drugs that could become the next acquisition targets for pharmaceutical giants.

Frequently Asked Questions